CORZ Core Scientific, Inc. | US21874A1060
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 1.037.314.560 | 626.136.440 | 65.67% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 0,30 | -1,04 | 128.53% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 3 | 2 | 50.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |